Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Essler

Showing results (181-190 of 309) with videos related to

Pageof 31
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2018
<sup>68</sup>Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boostLena Thomas, Steffi Kantz, Arthur Hung, et al.
Annals of Nuclear Medicine|March 17, 2019
Preliminary results of biodistribution and dosimetric analysis of [<sup>68</sup>Ga]Ga-DOTA<sup>ZOL</sup>: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseasesAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Blood|September 1, 2012
HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivoAndreas Weigert, Benjamin Weichand, Divya Sekar, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Multicentric <sup>68</sup>Ga-PSMA PET radiomics for treatment response assessment of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerRobin Gutsche, Gizem Gülmüs, Felix M Mottaghy, et al.
Gut and Liver|November 25, 2022
Factors Affecting the Learning Curve in the Endoscopic Ultrasound-Guided Sampling of Solid Pancreatic Lesions: A Prospective StudyMarcel Razpotnik, Simona Bota, Mathilde Kutilek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2007
Renal accumulation of [111In]DOTATOC in rats: influence of inhibitors of the organic ion transport and diureticsA R Stahl, B Wagner, T Poethko, et al.
Oncotargets and Therapy|October 19, 2017
Theranostics in nuclear medicine practiceAnna Yordanova, Elisabeth Eppard, Stefan Kürpig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2017
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
Quantifying the Renal Impact of [<sup>177</sup>Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN RegistryThomas Büttner, Christian Hoffmann, Markus Essler, et al.
EJNMMI Research|November 30, 2019
Biodistribution and post-therapy dosimetric analysis of [<sup>177</sup>Lu]Lu-DOTA<sup>ZOL</sup> in patients with osteoblastic metastases: first resultsAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Pageof 31

Showing results (181-190 of 309) with videos related to

Sort By:
Pageof 31
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2018
<sup>68</sup>Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boostLena Thomas, Steffi Kantz, Arthur Hung, et al.
Annals of Nuclear Medicine|March 17, 2019
Preliminary results of biodistribution and dosimetric analysis of [<sup>68</sup>Ga]Ga-DOTA<sup>ZOL</sup>: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseasesAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Blood|September 1, 2012
HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivoAndreas Weigert, Benjamin Weichand, Divya Sekar, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Multicentric <sup>68</sup>Ga-PSMA PET radiomics for treatment response assessment of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerRobin Gutsche, Gizem Gülmüs, Felix M Mottaghy, et al.
Gut and Liver|November 25, 2022
Factors Affecting the Learning Curve in the Endoscopic Ultrasound-Guided Sampling of Solid Pancreatic Lesions: A Prospective StudyMarcel Razpotnik, Simona Bota, Mathilde Kutilek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2007
Renal accumulation of [111In]DOTATOC in rats: influence of inhibitors of the organic ion transport and diureticsA R Stahl, B Wagner, T Poethko, et al.
Oncotargets and Therapy|October 19, 2017
Theranostics in nuclear medicine practiceAnna Yordanova, Elisabeth Eppard, Stefan Kürpig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2017
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
Quantifying the Renal Impact of [<sup>177</sup>Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN RegistryThomas Büttner, Christian Hoffmann, Markus Essler, et al.
EJNMMI Research|November 30, 2019
Biodistribution and post-therapy dosimetric analysis of [<sup>177</sup>Lu]Lu-DOTA<sup>ZOL</sup> in patients with osteoblastic metastases: first resultsAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Pageof 31